Virtual Screening of Natural Metabolites and Antiviral Drugs with Potential Inhibitory Activity against 3CL-PRO and PL-PRO

Abstract

Introduction SARS-CoV-2, identified in Wuhan (China) is the main etiologic agent causing of COVID-19, characterized by the clinical development of fever, cough, myalgias, dyspnea involving severe acute respiratory syndrome associated pneumonia. The World Health Organization (WHO) has confirmed